Pictet Asset Management Holding SA Sells 9,447 Shares of Humana Inc. $HUM

Pictet Asset Management Holding SA lessened its holdings in shares of Humana Inc. (NYSE:HUM) by 12.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 67,283 shares of the insurance provider’s stock after selling 9,447 shares during the quarter. Pictet Asset Management Holding SA owned approximately 0.06% of Humana worth $11,666,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. Revolve Wealth Partners LLC acquired a new stake in Humana during the 4th quarter valued at $202,000. Woodline Partners LP increased its holdings in shares of Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after purchasing an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC raised its position in shares of Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC raised its position in shares of Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after purchasing an additional 222 shares during the period. Finally, WINTON GROUP Ltd lifted its stake in shares of Humana by 58.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after buying an additional 879 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

HUM opened at $396.38 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $415.00. The firm has a market cap of $47.59 billion, a P/E ratio of 42.39, a price-to-earnings-growth ratio of 2.33 and a beta of 0.71. The business’s fifty day moving average is $318.28 and its 200-day moving average is $249.54.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the previous year, the business posted $11.58 earnings per share. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts expect that Humana Inc. will post 9.03 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Analysts Set New Price Targets

A number of research analysts recently commented on HUM shares. Weiss Ratings upgraded shares of Humana from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft cut Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Wolfe Research raised Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Finally, William Blair started coverage on Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $293.09.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.